Development and Validation of a UPLC Method for the Determination of Docetaxel and Its Related Substances in Pharmaceutical Dosage Forms, an Antineoplastic Agent
A novel, simple, and sensitive Ultra Performance Liquid Chromatography (UPLC) method was developed and validated for the quantification of process-related impurities and degradants, as well as the assay of Docetaxel. The stability-indicating capability of the method was demonstrated through forced degradation studies and a comprehensive mass balance evaluation. Chromatographic separation was achieved using an ACQUITY UPLC BEH C18 column (100 × 2.1 mm, 1.7 μm), with gradient elution. The mobile phase A comprised a mixture of water, methanol, and acetonitrile (500:300:200, v/v/v), while mobile phase B was acetonitrile and water (800:200, v/v). The flow rate was set at 0.4 mL/min, with detection at 232 nm using a photodiode array detector. The method exhibited excellent performance, with a tailing factor of 1.10 for Docetaxel. The method was rigorously validated for precision, accuracy, linearity, LOD, LOQ, ruggedness, specificity, and robustness. Forced degradation studies confirmed the method’s suitability for stability analysis. Stability testing on the drug substance was conducted following ICH guidelines.
References
[1]
Clarke, S.J. and Rivory, L.P. (1999) Clinical Pharmacokinetics of Docetaxel. ClinicalPharmacokinetics, 36, 99-114. https://doi.org/10.2165/00003088-199936020-00002
[2]
Naganjaneyulu, T. and Archana Devi, T. (2013) Extractive Spectrophotometric Methods for the Determination of Docetaxel in Pure and Pharmaceutical Formulations. Der Pharma Chemica, 5, 131-136
[3]
Seshagiri Rao, J.V.L.N., Mastanamma, S. and Prahlad, P. (2011) A Validated RP-HPLC Method for the Estimation of Docetaxel in Injectable Dosage Forms. International Journal of Research in Pharmaceutical and Biomedical Sciences, 82, 35-41.
[4]
Venishetty, V.K., Parikh, N., Sistla, R., Ahmed, F.J. and Diwan, P.V. (2011) Application of Validated RP-HPLC Method for Simultaneous Determination of Docetaxel and Ketoconazole in Solid Lipid Nanoparticles. JournalofChromatographicScience, 49, 136-141. https://doi.org/10.1093/chrsci/49.2.136
[5]
Malleswara Reddy, A. (2010) Evaluation of the Pharmaceutical Quality of Docetaxel Injection Using New Stability Indicating Chromatographic Methods for Assay and Impurities. ScientiaPharmaceutica, 78, 215-231. https://doi.org/10.3797/scipharm.0912-14
[6]
Suchitra, D., Chitrapu, P., et al. (2023) RP-HPLC Method Development and Validation for the Estimation of Docetaxel in Pharmaceutical Dosage Forms. Journal for Innovative Development in Pharmaceutical and Technical Science, 6, 15-21.
[7]
Venishetty, V.K., Parikh, N., Sistla, R., Ahmed, F.J. and Diwan, P.V. (2011) Application of Validated RP-HPLC Method for Simultaneous Determination of Docetaxel and Ketoconazole in Solid Lipid Nanoparticles. JournalofChromatographicScience, 49, 136-141. https://doi.org/10.1093/chrsci/49.2.136
[8]
Sheetal, M. (2013) A Simple Ultraviolet Spectro-Photometric Method for the Estimation of Docetaxel in Bulk Drug and Formulation. Asian Journal of Pharmaceutical Analysis, 3, 48-52.
[9]
Vasu Dev, R., Moses Babu, J., Vyas, K., Sai Ram, P., Ramachandra, P., Sekhar, N.M., et al. (2006) Isolation and Characterization of Impurities in Docetaxel. JournalofPharmaceuticalandBiomedicalAnalysis, 40, 614-622. https://doi.org/10.1016/j.jpba.2005.10.037
[10]
Kumar, D., Tomar, R.S., Deolia, S.K., Mitra, M., Mukherjee, R. and Burman, A.C. (2007) Isolation and Characterization of Degradation Impurities in Docetaxel Drug Substance and Its Formulation. JournalofPharmaceuticalandBiomedicalAnalysis, 43, 1228-1235. https://doi.org/10.1016/j.jpba.2006.10.015
[11]
Rao, B.M., Chakraborty, A., Srinivasu, M.K., Devi, M.L., Kumar, P.R., Chandrasekhar, K.B., et al. (2006) A Stability-Indicating HPLC Assay Method for Docetaxel. JournalofPharmaceuticalandBiomedicalAnalysis, 41, 676-681. https://doi.org/10.1016/j.jpba.2006.01.011
Ciccolini, J., Catalin, J., Blachon, M.F. and Durand, A. (2001) Rapid High-Performance Liquid Chromatographic Determination of Docetaxel (Taxotere) in Plasma Using Liquid-Liquid Extraction. JournalofChromatographyB: BiomedicalSciencesandApplications, 759, 299-306. https://doi.org/10.1016/s0378-4347(01)00238-9
[14]
Loos, W.J., Verweij, J., Nooter, K., Stoter, G. and Sparreboom, A. (1997) Sensitive Determination of Docetaxel in Human Plasma by Liquid-Liquid Extraction and Reversed-Phase High-Performance Liquid Chromatography. Journal of ChromatographyB: BiomedicalSciencesandApplications, 693, 437-441. https://doi.org/10.1016/s0378-4347(97)00089-3
[15]
Rouini, M.R., Lotfolahi, A., Stewart, D.J., Molepo, J.M., Shirazi, F.H., Vergniol, J.C., et al. (1998) A Rapid Reversed Phase High Performance Liquid Chromatographic Method for the Determination of Docetaxel (Taxotere®) in Human Plasma Using a Column Switching Technique. JournalofPharmaceuticalandBiomedicalAnalysis, 17, 1243-1247. https://doi.org/10.1016/s0731-7085(97)00233-1
[16]
Long Yu, J., Li Yan, Q. and Yi, J. (2006) HPLC for Determination of Docetaxel by Injection. Chinese Journal of Pharmaceuticals, 37, 708-709.
[17]
Yang, B., Zheng, L.X., Duan, G.L. and Chen, Z.Z. (2006) Determination of Docetaxel and Its Related Substances in Injections by HPLC. Journal of Fudan University, 33, 701-703.
[18]
Malleswara Reddy, A. (2010) Evaluation of the Pharmaceutical Quality of Docetaxel Injection Using New Stability Indicating Chromatographic Methods for Assay and Impurities. ScientiaPharmaceutica, 78, 215-231. https://doi.org/10.3797/scipharm.0912-14
[19]
Du, P., Li, N., Wang, H., Yang, S., Song, Y., Han, X., et al. (2013) Development and Validation of a Rapid and Sensitive UPLC-MS/MS Method for Determination of Total Docetaxel from a Lipid Microsphere Formulation in Human Plasma. JournalofChromatographyB, 926, 101-107. https://doi.org/10.1016/j.jchromb.2013.02.006
[20]
The United States Pharmacopeia (2009) Validation of Compendial Methods, 32nd edition. USP 32 Section. http://www.pharmacopeia.cn/v29240/usp29nf24s0_c1225.html
[21]
International Federation of Pharmaceutical Manufactures & Associations (IFPMA) (1996) Validation of Analytical Procedure. International Conference on Harmonization (ICH), Methodology Q2 (R1), Geneva, 6 November 1996.
[22]
Stability, I.C.H. (2003) Testing of New Drug Substances and Products Q1A (R2). Proceedings of the International Conference on Harmonization (IFPMA’03), Geneva, 6 February 2003.
